A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled, Large Simple Trial Evaluating the Use of BE1116 (4-Factor Prothrombin Complex Concentrate [Kcentra® / Beriplex® ]) to Improve Survival in Patients with Traumatic Injury and Acute Major Bleeding (NCT05568888)
CSL TAP
This trial is No longer recruiting
Registration number NCT05568888
Program & service
This trial is being run with the Surgery service, and as part of the Trauma program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Professor Mark Fitzgerald
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR